"10.1371_journal.pone.0117098","plos one","2015-01-20T00:00:00Z","Rajeev Malhotra; Megan F Burke; Trejeeve Martyn; Hannah R Shakartzi; Timothy E Thayer; Caitlin O’Rourke; Pingcheng Li; Matthias Derwall; Ester Spagnolli; Starsha A Kolodziej; Konrad Hoeft; Claire Mayeur; Pawina Jiramongkolchai; Ravindra Kumar; Emmanuel S Buys; Paul B Yu; Kenneth D Bloch; Donald B Bloch","Cardiovascular Research Center and Cardiology Division of the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Department of Anesthesiology, Uniklinik Aachen, RWTH Aachen University, Aachen, Germany; Acceleron Pharma, Inc. Cambridge, MA, United States of America; Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States of America; Center for Immunology and Inflammatory Diseases and the Division of Rheumatology, Allergy, and Immunology of the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America","Conceived and designed the experiments: RM MFB TM HRS MD ESB PBY KDB DBB. Performed the experiments: RM MFB TM HRS TET CO PL MD ES SAK KH CM PJ. Analyzed the data: RM MFB TM HRS TET CO. Contributed reagents/materials/analysis tools: RM RK PBY KDB DBB. Wrote the paper: RM MFB TM HRS TET CO PL MD ES SAK KH CM PJ RK ESB PBY KDB DBB.","Dr. Ravindra Kumar is an employee of Acceleron Pharma Inc. and has stock ownership in the company. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. The Massachusetts General Hospital has applied for patents related to pharmacologic BMP signaling inhibitors. These patents include: 1. Inhibitors of the bmp signaling pathway (Application # CA 2718403, PCT/US2009/001606). Drs. Yu and K. Bloch may be entitled to royalties. 2. Compositions and methods for cardiovascular disease (Application # PCT/US2012/022119). Drs. Malhotra, Derwall, Yu, and K. Bloch may be entitled to royalties. 3. Bmp inhibitors and methods of use thereof (Application # PCT/US2014/020360). Drs. Yu and K. Bloch may be entitled to royalties. These patents do not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.","2015","01","Rajeev Malhotra","RM",18,TRUE,9,13,6,18,TRUE,TRUE,FALSE,0,NA,FALSE
